However, despite evidence suggesting that cytokine-expressing B cell subsets can support immune modulation and tumor progression in murine models, via the secretion of IL-10,9 the role of circulating and intratumoral cytokine-expressing B cells in patients with melanoma has received insufficient attention. This evidence concerns the gene IL10 and neoplasm.